Advanced search
Publication Cover
Journal of Receptors and Signal Transduction Volume 34, 2014 - Issue 5
Submit an article Journal homepage
322
Views
10
CrossRef citations to date
0
Altmetric
Review Article

Role of miR-107 and its signaling pathways in diseases

Zong-Pei JiangDepartment of Nephrology, The Sixth Affiliated Hospital, Sun Yat-Sen University GuangzhouChina
&
Tian-Biao ZhouDepartment of Nephrology, The Sixth Affiliated Hospital, Sun Yat-Sen University GuangzhouChinaCorrespondence[email protected]
Pages 338-341 | Received 22 Jan 2014, Accepted 17 Feb 2014, Published online: 06 Mar 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tian-Biao Zhou. (2015) Signaling pathway factors expression in renal tissue of apoE-knockout mice. Journal of Receptors and Signal Transduction 35:5, pages 435-438.
Read now

Articles from other publishers (9)

A. Natalicchio, M. Montagnani, M. Gallo, N. Marrano, A. Faggiano, M.C. Zatelli, R. Mazzilli, A. Argentiero, R. Danesi, S. D’Oronzo, S. Fogli, D. Giuffrida, S. Gori, A. Ragni, V. Renzelli, A. Russo, T. Franchina, E. Tuveri, L. Sciacca, M. Monami, G. Cirino, G. Di Cianni, A. Colao, A. Avogaro, S. Cinieri, N. Silvestris & F. Giorgino. (2023) MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. ESMO Open 8:3, pages 101573.
Crossref
Lei Gong, Juan Chen & Xijiao Jiang. (2021) Circ_0005033 is an oncogene in laryngeal squamous cell carcinoma and regulates cell progression and Cisplatin sensitivity via miR-107/IGF1R axis. Anti-Cancer Drugs 33:3, pages 245-256.
Crossref
Ying Zhang, Cheng Zhang, Zongwei Chen & Meilan Wang. (2021) Blocking circ_UBR4 suppressed proliferation, migration, and cell cycle progression of human vascular smooth muscle cells in atherosclerosis. Open Life Sciences 16:1, pages 419-430.
Crossref
Zhen Zhang, Feng Li, Yonggui Tian, Ling Cao, Qun Gao, Chaoqi Zhang, Kai Zhang, Chunyi Shen, Yu Ping, Nomathamsanqa Resegofetse Maimela, Liping Wang, Bin Zhang & Yi Zhang. (2020) Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK–miR-107–Eomes–PD-1 Pathway. The Journal of Immunology 204:9, pages 2575-2588.
Crossref
Hongyan Ai, Wei Zhou, Zeqiang Wang, Guo Qiong, Zhouxi Chen & Shungang Deng. (2018) microRNAs‐107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1. Journal of Cellular Biochemistry 120:5, pages 8696-8705.
Crossref
Lin Shen, Yanyan Hu, Jianwei Lou, Sen Yin, Weiling Wang, Yuanyan Wang, Yong Xia & Wei Wu. (2019) CircRNA‑0044073 is upregulated in atherosclerosis and increases the proliferation and invasion of cells by targeting miR‑107. Molecular Medicine Reports.
Crossref
Wenjie Hu, Lin Wen, Fang Cao & Yexin Wang. (2019) Down-Regulation of Mir-107 Worsen Spatial Memory by Suppressing SYK Expression and Inactivating NF-ΚB Signaling Pathway. Current Alzheimer Research 16:2, pages 135-145.
Crossref
Sha Ke, Zhaohui Yang, Fei Yang, Xiaoming Wang, Juan Tan & Bo Liao. (2019) Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease. Yonsei Medical Journal 60:7, pages 640.
Crossref
Chen-Dan Zou, Wei-Ming Zhao, Xiao-Na Wang, Qiang Li, Hui Huang, Wan-Peng Cheng, Jian-Feng Jin, He Zhang, Ming-Juan Wu, Sheng Tai, Chao-Xia Zou & Xu Gao. (2015) MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma. Oncotarget 7:1, pages 266-278.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.